N
RCKT icon

Natixis’s Rocket Pharmaceuticals RCKT Stock Holding History

Natixis’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-48,400
Closed -$608K – 1158
2024
Q4 		$608K Buy
+48,400
New +$729K ﹤0.01% 673
2024
Q1 		– Sell
-649
Closed -$19.5K – 1194
2023
Q4 		$19.5K Hold
649
– – ﹤0.01% 880
2023
Q3 		$13.3K Sell
649
-11
-2% -$200 ﹤0.01% 883
2023
Q2 		$13.1K Sell
660
-34
-5% -$687 ﹤0.01% 922
2023
Q1 		$11.9K Hold
694
– – ﹤0.01% 888
2022
Q4 		$13.6K Buy
+694
New +$12.8K ﹤0.01% 989
2022
Q1 		– Sell
-225,394
Closed -$4.92M – 1296
2021
Q4 		$4.92M Buy
+225,394
New +$6.15M 0.02% 555

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return